7‐{Di­phenyl­[(tri­phenyl­phos­phine)­aurio]­phos­phine(1+)‐P}‐8‐methyl‐7,8‐dicarba‐nido‐undecaborate(1–) dichloro­methane hemi­solvate

The title compound, 7‐[(Ph₂P)Au(PPh₃)]‐8‐(CH₃)‐7,8‐nido‐C₂B₉H₁₀]·­0.5CH₂Cl₂ or [Au(C₁₅H₂₃B₉P)­(C₁₈H₁₅P)]·­0.5CH₂Cl₂, is the first reported gold derivative of the ligand [7‐­(Ph₂P)‐8‐(CH₃)‐7,8‐nido‐C₂B₉H₁₀]^?. It has a mono­nuclear structure with the gold centre in an essentially linear coordination [P—Au—P 174.041 (15)°]. The open C₂B₃ face contains one H atom that is strongly bonded to the central B atom and semi‐bridging to a neighbouring B atom [B—H distances 1.070 (16) and 1.45 (3) Å].     

Ten‐vertex rhodadithiaborane ­chemistry: [8‐{I(CH2)5}‐3‐(η5‐C5Me5)‐arachno‐3,7,8‐RhS2B8H9]

Neutral 8‐(5‐iodo‐n‐pentyl)‐3‐(η⁵‐penta­methyl­cyclo­pentadi­enyl)‐arachno‐3‐rhoda‐7,8‐di­thia­undecaborane, [Rh(C₅H₁₉B₈­IS₂)­(C₁₀H₁₅)], obtained from the [arachno‐7,8‐S₂B₉H₁₀]^? anion by treatment with I(CH₂)₅I followed by [Rh(C₅Me₅)Cl₂]₂ and N,N,N′,N′‐tetra­methyl‐1,8‐di­amino­naphthalene, has the 11‐vertex cluster geometry of [arachno‐7,8‐S₂B₉H₁₀]^?, but with an {Rh(C₅Me₅)} unit in the 3‐position instead of a {BH} unit, and with a –(CH₂)₅I chain attached exo to an S atom.     

A 1,3,2‐ox­aza­borolidine dimer derived from (S)‐α,α‐di­phenyl­prolinol

The reaction of (S)‐α,α‐di­phenyl­prolinol with an excess of borane–tetra­hydro­furan complex yields a stable crystalline material with the composition C₃₄H₃₈B₂N₂O₂, which features a borane adduct of a spiro­cyclic structure with two ox­aza­borolidine rings joined by a central tetrahedral B atom. This dimeric ox­aza­borolidine complex, viz. 3,3,3′,3′‐tetra­phenyl‐1,1′‐spiro­bi(3a,4,5,6‐tetra­hydro‐3H‐pyrrolo­[1,2‐c][1,3,2]­ox­azaborole)–7‐borane, is the dominant product under various reaction conditions; its crystal structure is consistent with ¹¹B, ¹H and ¹³C NMR and IR analyses.     

[Et4N][7‐Me2S‐nido‐B11H12]

Tetraethyl­ammonium 7‐di­methyl­sulfanyl‐nido‐dodeca­hydro­undecaborate, [Et₄N][7‐Me₂S‐nido‐B₁₁H₁₂] or C₈H₂₀N⁺·C₂H₁₈B₁₁S⁻, is a product of the deprotonation of [7‐Me₂S‐nido‐B₁₁H₁₃] with KHBEt₃ and precipitation with tetraethyl­ammonium chloride. The effect of removing one endo‐terminal H atom is to cause a general contraction of the open‐face B—B distances.     

16‐[3‐Methoxy‐4‐(2‐piperidin‐1‐yl­ethoxy)­benzyl­idene]‐17‐oxoandrost‐5‐en‐3β‐yl acetate monohydrate

The title compound, C₃₆H₄₉NO₅·H₂O, has the outer two six‐membered rings of the steroid nucleus in chair conformations. The central ring B of the steroid nucleus is in an 8β,9α‐half‐chair conformation, while ring D of the steroid adopts a slightly distorted 13β,14α‐half‐chair conformation. The piperidine ring is in a chair conformation. The methoxy­benzyl­idene moiety has an E configuration with respect to the carbonyl group at position 17. Intermolecular O—H?O and O—H?N hydrogen bonds link the steroid and water mol­ecules into chains which run parallel to the b axis.     

The dimeric mixed‐ligand titana­carborane sandwich [1‐(Cp)‐1‐Ti‐2‐(Me)‐3‐(SiMe3)‐2,3‐C2B4H4]2

The title dimer, bis­[1‐cyclo­penta­dienyl‐2‐methyl‐1‐titana‐3‐tri­methylsilyl‐2,3‐dicarba‐closo‐hexaborane(6)], [Ti(C₅H₅)(C₆­H₁₆­B₄Si)]₂, reveals that the centrosymmetric mol­ecule consists of two bent‐sandwich titanacarboranes bridged by the B—H—Ti bonds. The average bond distances are Ti—B 2.445 (3), Ti—C(cage) 2.334 (2) and Ti—C(Cp) 2.376 (3) Å, and the corresponding bond angles are Cp—Ti—Cp 163.2 (1) and Cp—Ti—Cb (Cb = C₂B₃ face) 139.9 (1)°; the Ti—H separations are 2.10 (2) and 2.19 (2) Å.     

16‐(4‐Cyano­benzyl­idene)‐17‐oxo­androst‐5‐en‐3β‐ol

In the title compound, 4‐(3β‐hydroxy‐17‐oxoandrost‐5‐en‐16‐ylidenemethyl)benzonitrile, C₂₇H₃₁NO₂, rings A and C of the steroid nucleus are in chair conformations. The central six‐membered ring B is in an 8β,9α‐half‐chair conformation, while the five‐membered ring D adopts a 13β,14α‐half‐chair conformation. The cyano­benzyl­idene moiety has an E configuration with respect to the carbonyl group at position C17. The dihedral angle between the planes of the steroid nucleus and the cyano­benzyl­idene moiety is 22.61 (15)°. Intermolecular O—H⃛N hydrogen bonds formed between the hydroxyl group of the steroid and the N atom of the cyano­benzyl­idene moiety of symmetry‐related mol­ecules link the steroid mol­ecules into chains which run parallel to the b axis.     

Three monoalkoxy‐substituted nido‐platinaboranes: [(PPh3)2PtB10H11‐8‐(OCH3)], [(PPh3)2PtB10H11‐8‐{OCH(CH3)2}] and [(PPh3)2PtB10H10‐9‐{OCH(CH3)2}]

Each of the title compounds, 8‐methoxy‐7,7‐bis­(tri­phenyl­phosphine‐P)‐8,9:10,11‐di‐μH‐7‐platina‐nido‐undecaborane di­chloro­methane hemisolvate, [Pt(CH₁₄B₁₀O)(C₁₈H₁₅P)₂]·0.5CH₂Cl₂, (I), 8‐isopropoxy‐7,7‐bis­(tri­phenyl­phosphine‐P)‐8,9:10,11‐di‐μH‐7‐platina‐nido‐undecaborane di­chloro­methane solvate, [Pt(C₃H₁₈B₁₀O)(C₁₈H₁₅P)₂]·CH₂Cl₂, (II), and 9‐isopropoxy‐7,7‐bis­(tri­phenyl­phosphine‐P)‐8,9:10,11‐di‐μH‐7‐platina‐nido‐undecaborane di­chloro­methane solvate, [Pt(C₃H₁₈B₁₀O)(C₁₈H₁₅P)₂]·CH₂Cl₂, (III), has an 11‐vertex nido polyhedral skeleton, with the 7‐platinum centre ligating to two exo‐polyhedral PPh₃ groups and an alkoxy‐substituted polyhedral borane ligand. Compounds (II) and (III) are isomers. The Pt—B distances are in the range 2.214 (7)–2.303 (7) Å for (I), 2.178 (16)–2.326 (16) Å for (II) and 2.205 (6)–2.327 (6) Å for (III).     

3α‐Tosyl­oxy­methyl­tropane(N8–B)borane

The title compound [alternative name: 8‐methyl‐8‐aza­bi­cyclo­[3.2.1]­octan‐3‐yl­methyl p‐toluene­sulfonate(N⁸—B)–bor­ane], C₁₆H₂₆BNO₃S, has the tosyl­oxy­methyl substituent in an endo position. The BH₃ group is equatorial and the (N‐bonded) methyl group is axial, relative to the six‐membered heterocycle. The N—B bond of 1.649 (8) Å is one of the longest known.     

[1,1,2,2‐(CO)4‐1,2‐μ‐(CO)‐4,11‐(SMe2)2‐closo‐1,2‐Co2B10H8]

The title compound, 1,1,2,2‐tetra­carbonyl‐1,2‐μ‐carbonyl‐4,11‐di­methyl­sulfido‐closo‐1,2‐dicobaltadodecaborane, [Co₂(C₄H₂₀B₁₀S₂)(CO)₅], has a closo 12‐vertex {1,2‐Co₂B₁₀H₈} structure with SMe₂ ligands at the exo‐4‐ and 11‐positions. The cluster displays close structural similarities to the SEt₂ analogue.     

2,6‐Di­benzyl‐1,2,3,5,6,7‐hexa­hydro‐2,4,6,8‐tetra­aza‐s‐indacene and 2,6‐bis(4‐methoxy­benzyl)‐1,2,3,5,6,7‐hexa­hydro‐2,4,6,8‐tetra­aza‐s‐indacene

The title compounds, C₂₂H₂₂N₄ and C₂₄H₂₆N₄O₂ [alternative names: 2,6‐dibenzyl‐2,3,6,7‐tetrahydro‐1H,5H‐dipyrrolo[3,4‐b; 3′,4′‐e]pyrazine and 2,6‐bis(4‐methoxybenzyl)‐2,3,6,7‐tetrahydro‐1H,5H‐dipyrolo[3,4‐b;3′,4′‐e]pyrazine], two 1,2,3,5,6,7‐hexa­hydro‐2,4,6,8‐tetra­aza‐s‐indacene derivatives, are both centrosymmetric and have similar S‐shaped structures. In the former, there are two independent mol­ecules (A and B), both of which possess C_i symmetry. These two mol­ecules are arranged such that the benzene ring substituent of mol­ecule B is directed towards the plane of the benzene ring substituent of mol­ecule A, with a dihedral angle of 55.4 (2)° between their planes. The shortest C—H⋯C distance is, however, only 3.21 (1) Å. In both compounds, the benzene ring substituents are almost perpendicular to the plane of the central pyrazine ring, and the pyrrolidine rings have perfect envelope conformations. In the crystal structures of both compounds, the mol­ecules pack in a herring‐bone arrangement.     

9(R)‐[6(R)‐Hydroxy­methyl‐1‐oxa‐4‐thia­cyclo­hexan‐2‐yl]hypoxanthine–water (4/3), a nucleoside analogue

The title compound, 9(R)‐[6(R)‐hydroxy­methyl‐1‐oxa‐4‐thia­cyclo­hexan‐2‐yl]‐1,9‐di­hydro‐6H‐purin‐6‐one–water (4/3), C₁₀H₁₂N₄O₃S·0.75H₂O, crystallizes in the triclinic space group P1 with four mol­ecules in the asymmetric unit and 0.75 waters of hydration per mol­ecule. The structure was refined to an R value of 0.072 for 3382 observed reflections. The four crystallographically independent mol­ecules are designated A, B, C and D. All four oxa­thia­ne rings adopt the chair conformation and the purine bases are in an anti orientation with respect to the sugar moieties. Molecules A and D and mol­ecules C and B are base paired by a single hydrogen bond of the type N—H?N. These base pairs are again hydrogen bonded to their translated pairs in the direction of a cell diagonal.     

η5‐(3)‐1‐Methyl‐1,2‐dicarbollyl‐η5‐2′,5′‐dimethylpyrrolylcobalt(III)

In the title compound, (η⁵‐2,5‐di­methyl­pyrrolyl)[(7,8,9,10,11‐η)‐7‐methyl‐7,8‐dicarba‐nido‐undecaborato]­cobalt(III), [3‐Co{η⁵‐[2,5‐(CH₃)₂‐NC₄H₂]}‐1‐CH₃‐1,2‐C₂B₉H₁₀] or [Co(C₃H₁₃B₉)(C₆H₈N)], the Co^III atom is sandwiched between the pentagonal faces of the pyrrolyl and dicarbollide ligands, resulting in a neutral mol­ecule. The C—C distance in the dicarbollide cage is 1.649 (3) Å.     

Polyhedral aza­borane chemistry, 6‐(C5H5N)‐arachno‐4‐NB8H11

The title compound, 6‐pyridyl‐4‐aza‐arachno‐nonaborane(11), C₅H₁₆B₈N₂, has an arachno nine‐vertex {4‐NB₈H₁₁} cluster structure with a pyridine ligand in the exo‐6‐position. The cluster has close geometric similarities to the thia­borane and carbaborane analogues.     

4‐Methyl‐N‐[2‐(p‐tolylsulfanyl)phenyl]benzene­sulfonamide

The title compound, C₂₀H₁₉NO₂S₂, is formed by a palladium–copper‐catalyzed reaction between 4‐methyl‐N‐[2‐(prop‐2‐ynyl­sul­fanyl)­phenyl]­benzene­sul­fon­amide and p‐iodo­toluene. The mol­ecules contain three essentially planar parts, namely an amino­thio­phenol moiety (A), a toluene­sulfone moiety excluding the oxo ligands (B) and a tolyl group (C), approximately orthogonal to each other; the dihedral angles A/B, A/C and B/C are 111.6 (1), 89.3 (1) and 101.4 (1)°, respectively. Intermolecular N—H?O hydrogen bonds link the mol­ecules into infinite one‐dimensional chains.     

6‐(2‐Hydro­xy­benzoyl)‐5‐(pyrrol‐2‐yl)‐3H‐pyrrolizine

The title compound, 2‐hydroxy­phenyl 5‐(pyrrol‐2‐yl)‐3H‐pyrrolizin‐6‐yl ketone, C₁₈H₁₄N₂O₂, was isolated from the base‐catalyzed 1:2 condensation of 2‐hydroxy­aceto­phenone with pyrrole‐2‐carbaldehyde. The pyrrole N—H and hydroxy­benzoyl O—H groups are hydrogen bonded to the benzoyl O atom. The allyl­ic C=C double bond of the 3H‐pyrrolizine system is located between ring positions 1 and 2, the C atom at position 3 (adjacent to the N atom) being single bonded.     

A `tetrameric' 3,4‐di‐p‐tolyl‐1,2,5‐oxadiborole derivative

In the title compound, 1,1,6a,7,9a,10‐hexa­chloro‐2,3,5,6,8,9,11,12‐octa‐p‐tolyl‐1,6a,9a,12a‐tetraborata‐3a,4a,7,10‐tetrabora‐4a¹,6b,9b,12b‐tetraoxonia‐4‐oxatetra­cyclo­penta­[1,2‐a:2,1,5‐de:1,2‐g:1,2‐i]­naphthalene di­chloro­methane pentasolvate, C₆₄H₅₆B₈Cl₆O₅·5CH₂Cl₂, two condensed oxadiborole rings are attached to two further oxadiborole rings in a type of donor–acceptor bonding, thus forming a ten‐membered alternating (B—O)₅ naphthalene‐like arrangement as the central building block.     

Crystal engineering with heteroboranes. II. 1,2‐Di­carboxy‐1,2‐dicarba‐closo‐dodecaborane(12) ethanol hemisolvate

The title compound, 1,2‐(COOH)₂‐1,2‐closo‐C₂B₁₀H₁₀·0.5C₂H₆O or C₄H₁₂B₁₀O₄·0.5C₂H₆O, forms a tetramer by incorporating ethanol (solvent) mol­ecules through hydrogen bonding. Two eight‐membered rings [graph set R(8)] are formed by hydrogen bonding between two carboxyl­ic acid groups, whereas two ten‐membered rings [R(10)] are formed by hydrogen bonding between two carboxyl­ic acid groups and the OH group of an ethanol mol­ecule (solvent). Two crystallographically independent tetramers are present in the crystal structure.     

tert‐Butyl (6S)‐4‐hydroxy‐6‐isobutyl‐2‐oxo‐1,2,5,6‐tetra­hydropyridine‐1‐carboxyl­ate and tert‐butyl (4R,6S)‐4‐hydroxy‐6‐iso­butyl‐2‐oxopiperidine‐1‐carboxyl­ate

X‐ray studies reveal that tert‐butyl (6S)‐6‐iso­butyl‐2,4‐dioxo­piperidine‐1‐carboxyl­ate occurs in the 4‐enol form, viz. tert‐butyl (6S)‐4‐hydroxy‐6‐iso­butyl‐2‐oxo‐1,2,5,6‐tetra­hydropyri­dine‐1‐carboxyl­ate, C₁₄H₂₃NO₄, when crystals are grown from a mixture of di­chloro­methane and pentane, and has an axial orientation of the iso­butyl side chain at the 6‐position of the piperidine ring. Reduction of the keto functionality leads predominantly to the corresponding β‐hydroxy­lated δ‐lactam, tert‐butyl (4R,6S)‐4‐hydroxy‐6‐iso­butyl‐2‐oxo­piperidine‐1‐car­boxyl­ate, C₁₄H₂₅NO₄, with a cis configuration of the 4‐hydroxy and 6‐iso­butyl groups. The two compounds show similar molecular packing driven by strong O—H⋯O=C hydrogen bonds, leading to infinite chains in the crystal structure.     

Three isomeric forms of hydroxyphenyl‐2‐oxazoline: 2‐(2‐hydroxyphenyl)‐2‐oxazoline, 2‐(3‐hydroxyphenyl)‐2‐oxazoline and 2‐(4‐hydroxyphenyl)‐2‐oxazoline

Crystal structures are reported for three isomeric compounds, namely 2‐(2‐hydroxy­phenyl)‐2‐oxazoline, (I), 2‐(3‐hydroxy­phenyl)‐2‐oxazoline, (II), and 2‐(4‐hydroxy­phenyl)‐2‐oxazoline, (III), all C₉H₉NO₂ [systematic names: 2‐(4,5‐dihydro‐1,3‐oxazol‐2‐yl)phenol, (I), 3‐(4,5‐dihydro‐1,3‐oxazol‐2‐yl)phenol, (II), and 4‐(4,5‐dihydro‐1,3‐oxazol‐2‐yl)phenol, (III)]. In these compounds, the deviation from coplanarity of the oxazoline and benzene rings is dependent on the position of the hydroxy group on the benzene ring. The coplanar arrangement in (I) is stabilized by a strong intra­molecular O—H⋯N hydrogen bond. Surprisingly, the 2‐oxazoline ring in mol­ecule B of (II) adopts a ³T₄ (^C2T_C3) conformation, while the 2‐oxazoline ring in mol­ecule A, as well as that in (I) and (III), is nearly planar, as expected. Tetra­mers of mol­ecules of (II) are formed and they are bound together via weak C—H⋯N hydrogen bonds. In (III), strong inter­molecular O—H⋯N hydrogen bonds and weak intra­molecular C—H⋯O hydrogen bonds lead to the formation of an infinite chain of mol­ecules perpendicular to the b direction. This paper also reports a theoretical investigation of hydrogen bonds, based on density functional theory (DFT) employing periodic boundary conditions.